SurGenTec Gains FDA Clearance for OsteoFlo NanoPutty

SurGenTec OsteoFlo NanoPutty

SurGenTec received FDA 510(k) clearance to market OsteoFlo® NanoPutty®, a quadphasic synthetic bone graft. Product launch is slated for 4Q20.

Quadphasic scaffolding supports bone growth at different phases during the healing process. Nano surface technology increases surface area and stimulates cellular activity/osseointegration. Quadphasic...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us